ATXN2 and amyotrophic lateral sclerosis: In a subset of 1,362 patients with ALS, Glass et al. (2022) confirmed that ≥31 polyQ repeats in ATXN2 increased the risk for ALS, and the risk for ALS with FTD was even greater.